Generic Name(s): Belatacept
Drug Class: Immunosuppressant
Treats: Prevent organ rejection during transplant
Nulojix is the brand name of the drug Belatacept. Nulojix is an immunosuppressant that blocks the T-cell pathway. Nulojix is used in adult patients during a kidney transplant. Nulojix limits the toxicity generated by calcineurin inhibitors. Nulojix is not recommended to be used in liver transplant patients due to increased risk of graft loss and death.
Nulojix Discount Coupon - Save Up To 75%** Off!
The free Pharmacy Coupons Nulojix Coupon and Discount Card can save you up to 75%** off your prescription prices. All you have to do is print the coupon and bring it to the pharmacy to receive the benefits of our drug discount program. This coupon is not insurance and is not valid in combination with any government-sponsored drug plans.
Nulojix is used together with other drugs such as mycophenolate and corticosteroids to allow organs to function normally. Nulojix prevents organ rejection in people who have received kidney transplant. Nulojix is an immunosuppressant, it works by weakening the immune system, and thus Nulojix contribute to preventing the body from rejecting new organs transplanted in the body.
Nulojix can also be used to reduce the toxic substances produced by the body during a transplant, it blocks the T-cell pathway to prevent these cells from getting infections during operation. Nulojix should be used efficiently in order to realize its real.
- Organ rejection for kidney transplant
Nulojix dosage is dependent on the individual that it is being administered to. The following dosage is an average dose and could differ among individuals. Follow your medical professional's directions for best results.
Nulojix is administered in combination with basiliximab and corticosteroids. Corticosteroid usage should be consistent with Nulojix as indicated by clinical trial experience. Administration of higher than the recommended dose or more frequent dosing of Nulojix is not recommended. Patients do not require medication shortly before administration of Nulojix because it is intravenous infusion only. Dosage recommended for Nulojix is as bellow:
- Day 1 of transplantation and day 5; 10 mg/kg.
- End of week 2 and week four after transplantation; 10 mg per kg.
- End of 8th and 12th week after transplantation; 10 mg/kg.
- End of week 16 after transplant and every four weeks after that; 5 mg/kg.
Nulojix Side Effects
Nulojix is usually associated with increased risk for post-transplant in the central nerve system. Nulojix is not recommended in patients who are EBV seronegative; this may cause an adverse reaction to health. Seek emergency help if you experience signs of allergic reactions such as difficulty in breathing or swallowing, hive and with lips and tongue. Severe and fatal infections may occur during administration of Nulojix.
Seek immediate help if you experience signs of diseases such as:
Nulojix interacts with other medication in the body to produce a hypersensitive reaction causing allergy such as; difficulty in breathing and swallowing. Only patients who are EBV seropositive are limited to the use of Nulojix. You must ensure that you discuss with the doctor about the drugs you use in your past in order to avoid problems associated with Nulojix. Some of the medications that may interact with Nulojix are as follows: